Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSF-470 Vaccine vs Interferon-alpha 2b in Cutaneous Melanoma
NCT01729663Phase 3Unknown
- Sponsor
- Laboratorio Pablo Cassará
- Start
- Apr 2009
- Primary completion
- Dec 2018
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of CSF-470 vaccine in cutaneous melanoma (CM), sponsored by Laboratorio Pablo Cassará. Status: unknown.
02
Drugs
CSF-470 vaccine
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT01729663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01729663.